By releasing the market's first cloud-based digital in vivo journal in 2019, VivoLogica assists researchers with a system compliant with 3R and research regulations. VivoLogica now plays a significant role in the field of in vivo studies with some of the foremost academic and R&D labs using our best-in-class multi-platform. VivoLogica is dedicated to empowering all phases of medical research through technology - beginning with the in vivo phase. Our system has helped academic, and R&D labs to save up to 75% by assisting them with the following; - Personalized dashboard adaptable to your specific needs. - Automated calculations of drug dosage and formulas. - Scheduling of daily activities with to-do lists and notifications. - Automated critical condition alerts to secure compliance, 3R and animal welfare. - Automatic logging of all activities and changes in compliance with 2010/63/EU. "VivoLogica provides a cutting-edge technology enabling us to work as safely and efficiently as possible with our in vivo studies." - Björn Platzack, Director Chemical and Pharmaceutical Safety at Research Institutes of Sweden, RISE.